{"certainAgreement":{"otherDetails":"The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.","piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true},"limitationsAndCaveats":{"description":"Study stopped due to strategic reasons. The decision was not based on specific safety findings as the safety observed in the phase II part of the study is in line with what was reported in the phase I part."},"pointOfContact":{"email":"clinicaltrials@nervianoms.com","organization":"Nerviano Medical Sciences S.r.l.","phone":"+39 0331-581111","title":"Lisa Mahnke"}}